Immunotherapy of osteosarcoma based on immune microenvironment modulation

Immunotherapy of osteosarcoma based on immune microenvironment modulation

Osteosarcoma is a highly malignant tumor with unsatisfactory therapeutic outcomes achieved by chemotherapy, radiotherapy, and surgery. As an emerging oncological treatment, immunotherapy has shown potential in the clinical management of many tumors but has a poor response rate in osteosarcoma. The i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Heping Lian, Jiakui Zhang, Shuna Hou, Shuang Ma, Jiachen Yu, Wei Zhao, Duoyi Zhao, Zhiyu Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	immunotherapy immune microenvironment biomaterials targeted therapy osteosarcoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1498060/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
by: Cong Luo, et al.
Published: (2025-01-01)

Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
by: Lin Zhang, et al.
Published: (2025-01-01)

Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
by: Yunxiang Hu, et al.
Published: (2025-02-01)

A telomere-related signature for predicting prognosis and assessing immune microenvironment in osteosarcoma
by: Shihao Li, et al.
Published: (2025-01-01)

Exploration of metastasis-related signatures in osteosarcoma based on tumor microenvironment by integrated bioinformatic analysis
by: Shiyao Liao, et al.
Published: (2025-01-01)

NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance
by: Shaoyan Shi, et al.
Published: (2025-01-01)

The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
by: Si Chen, et al.
Published: (2024-09-01)

Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
by: Minni Zhang, et al.
Published: (2025-01-01)

Tumor microenvironment–responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy
by: Qi Yang, et al.
Published: (2025-01-01)

Patient-matched tumours, plasma, and cell lines reveal tumour microenvironment- and cell culture-specific microRNAs
by: Latasha Ludwig, et al.
Published: (2024-12-01)

Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics
by: BingBing Li, et al.
Published: (2025-02-01)

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
by: Liubov A. Tashireva, et al.
Published: (2025-01-01)

Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation
by: Lei Sun, et al.
Published: (2025-01-01)

Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression
by: Mingzhen Zhou, et al.
Published: (2025-01-01)

An analysis of extraskeletal osteosarcoma based on the literature
by: De-Hui Wang, et al.
Published: (2025-01-01)

Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy
by: Dongming Li, et al.
Published: (2025-01-01)

The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
by: Dongqi Li, et al.
Published: (2025-12-01)

Bone‐Targeted Fluoropeptide Nanoparticle Inhibits NF‐κB Signaling to Treat Osteosarcoma and Tumor‐Induced Bone Destruction
by: Lin Li, et al.
Published: (2025-01-01)

Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01)

Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms
by: Jiali Yao, et al.
Published: (2025-01-01)

Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01)

Tumor microenvironment and immunotherapy for triple-negative breast cancer
by: Zijie Guo, et al.
Published: (2024-12-01)

The Immune Landscape and Its Potential for Immunotherapy in Advanced Biliary Tract Cancer
by: Andry Santoso, et al.
Published: (2024-12-01)

Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma
by: Yidan Shan, et al.
Published: (2025-01-01)

Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment
by: Shaoyan Shi, et al.
Published: (2025-02-01)

OSTEOSARCOMA HAS NOT BECOME ATTENTION TO SOCIETY PROFILE OF OSTEOSARCOMA PATIENTS AT DR. SOETOMO GENERAL HOSPITAL SURABAYA "A RETROSPECTIVE STUDY”
by: Ferdiansyah Mahyudin, et al.
Published: (2019-12-01)

Integrative analysis of ferroptosis in the hypoxic microenvironment of gastric cancer unveils the immune landscape and personalized therapeutic strategies
by: Xiao Xu, et al.
Published: (2025-01-01)

Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma
by: Yan Liao, et al.
Published: (2025-01-01)

Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
by: Said SS, et al.
Published: (2025-01-01)

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity
by: Ziwei Gao, et al.
Published: (2025-01-01)

T cell receptor signaling pathway subgroups and construction of a novel prognostic model in osteosarcoma
by: Huan Xu, et al.
Published: (2025-01-01)

ANALYSIS OF IMMUNITY IN OSTEOSARCOMA AS A BASIS FOR DEVELOPMENT FOLLOWING THERAPY
by: Ferdiansyah Mahyudin, et al.
Published: (2019-12-01)

Inhibition of id-1 reduces osteosarcoma growth and metastasis through mediation of snail
by: Rongbing Shu, et al.
Published: (2025-01-01)

Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma
by: Shibing Zhao, et al.
Published: (2025-01-01)

Editorial: Mechanism explorations of enhancing immunotherapeutic sensitivity via mediating immune infiltration and programmed cell death in solid tumor microenvironment
by: Fang Zheng, et al.
Published: (2025-01-01)

Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
by: Yunyan Dai, et al.
Published: (2025-01-01)

Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategies
by: Fu Zhao, et al.
Published: (2025-01-01)

Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma
by: Fushan Gao, et al.
Published: (2024-12-01)

Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
by: Xiang Wang, et al.
Published: (2025-01-01)

Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
by: Xinbo Gao, et al.
Published: (2025-01-01)